Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
about
Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma
P2860
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@ast
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@en
type
label
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@ast
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@en
prefLabel
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@ast
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@en
P2093
P2860
P50
P1433
P1476
Evaluation of treatment respon ...... ing (PET/MRI); The REMAP study
@en
P2093
Giovanni Montana
Paul Nathan
Sarah Rudman
P2860
P2888
P356
10.1186/S12885-017-3371-9
P407
P577
2017-06-02T00:00:00Z
P6179
1085759667